Approval Launch

Category
Continent
From
To
 
Johnson & Johnson’s IMAAVY Secures FDA Priority Re...

Johnson & Johnson’s IMAAVY Secures FDA Priority Re...

Category : Approval/Launch 28 April 2026

Johnson & Johnson has received Priority Review designation from the U.S. Food and Drug Administr...
Apotex, Orbicular & Gland Pharma Secure Dual ANDA...

Apotex, Orbicular & Gland Pharma Secure Dual ANDA...

Category : Approval/Launch 17 April 2026

In a market where complexity often deters competition, three companies have just executed a near tex...
GSK Expands Exdensur’s Reach in China: A New Optio...

GSK Expands Exdensur’s Reach in China: A New Optio...

Category : Approval/Launch 10 April 2026

Global biopharma leader GSK plc has secured another regulatory win in China. China’s Nation...
Cipla Expands U.S. Respiratory Portfolio with Appr...

Cipla Expands U.S. Respiratory Portfolio with Appr...

Category : Approval/Launch 3 April 2026

Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087) (NSE: CIPLA) (hereafter ref...
GSK Scores a First: FDA Approves Lynavoy for Chron...

GSK Scores a First: FDA Approves Lynavoy for Chron...

Category : Approval/Launch 23 March 2026

Some conditions are overlooked—not because they’re rare, but because they’re misun...

Categories

Latest Newsletter Post

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!